Basic Information
ID: ALA3590997
Type: Functional
Description: Reduction in GFP expression in human LNCAP cells transfected with plasmids co-expressing GFP and shRNAs against REV-ERBbeta followed by compound treatment 24 hrs post-transfection and measured 48 hrs post dose
Format: BAO_0000219
Organism: Homo sapiens
Cell type: LNCaP
Target: LNCaP(ALA612518)
Document: ALA3588752
Reduction in GFP expression in human LNCAP cells transfected with plasmids co-expressing GFP and shRNAs against REV-ERBbeta followed by compound treatment 24 hrs post-transfection and measured 48 hrs post dose: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3590997
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 319.88 | 4.81 | 4.81 |